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Diffuse primary angiosarcoma of the pleura:
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Abstract
Primary pleural angiosarcoma is an extremely rare tumor. We report the case of a patient who presented with recurrent
massive bilateral hemothoraxes. Although thoracoscopy was performed, biopsy samples of the pleura were inconclusive.
The delayed onset of skin metastases led to the diagnosis of angiosarcoma, however the patient died from pleuropulmonary
progression before treatment could be started. We review the literature of primary pleuropulmonary angiosarcoma and
discuss its treatment modalities.
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Case report
A 61 year old caucasian male with no signifi-
cant prior medical history was admitted for a
spontaneous right hemothorax for which he under-
went drainage and repeated blood transfusions. He
rapidly relapsed, with the onset of a left hemothorax
that was drained as well. CT-scan confirmed the
hemothorax, but there was no evidence of mediasti-
nal or lung abnormality (Figure 1). Bronchoscopy
revealed no abnormality or intraluminal bleeding
Angiography revealed hilar and peri-hilar hyper-
vascularization as well as a vascular blush from thin
collaterals of the right bronchial artery that was
subsequently embolized with 500–700mm embo-
spheres (Boston Scientific). Abdominal ultrasonog-
raphy was unremarkable. The patient underwent
a diagnostic thoracoscopy that was inconclusive and
only partial, in the setting of massive pleural bleeding
and multiple pleural septa. One month later, a small
hypervascularized lesion appeared on the left cheek,
associated with gingival bleeding. Biopsy of the
skin revealed malignant proliferation with large
cells in mitosis, dissociated by hemorrhage (Fig. 2).
Immunohistochemistry was negative for cytokeratin,
desmin, leukocyte common antigen and carcinoem-
bryonic antigen, but positive for CD31 and vimentin,
leading to the diagnosis of an angiosarcoma, the
patient was referred to our center, two months after
the onset of the first symptoms. On clinical
examination, he had a poor performance status
(ECOG 3). He complained of fatigue, dyspnea,
and had gingival bleeding. Cutaneous nodules had
appeared on his back, consistent with secondary
localizations of angiosarcoma. Blood count showed
52.10
3/l leucocytes with 48.10
3/l neutrophils,
88g/l hemoglobin and 196.10
9 platelets. Hemostasis
was normal. Tumor markers were normal except for
a slightly elevated CA125 at 59U/ml, probably
explained by the hemothorax. Blood chemistry was
normal. Despite transfusions, and supportive care,
the outcome was unfavorable and the patient died of
acute respiratory failure before specific therapy could
be started. An autopsy was performed, and con-
firmed the diagnosis of bilateral pulmonary angio-
sarcoma, with cutaneous and mucosal metastases.
Discussion
Primary angiosarcoma of the chest wall or pleura
is a rare condition and has a very poor prognosis.
1
Angiosarcomas represent 1 to 2% of soft tissue
tumors.
2,3 It originates from endothelial cells from
small blood vessels, and may affect a variety of
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4–6 Lung
metastases from extrathoracic angiosarcoma have
been described and are common in the natural
history of angiosarcoma.
7 Patients with primary
chest wall/lung angiosarcoma are often diagnosed
in the setting of massive, recurrent hemothorax,
although pain, chest wall mass, swelling or hemop-
tysis may represent the clinical picture.
1–3,8,9
However, as opposed to tumors arising from the
chest wall, pleuropulmonary angiosarcoma patients
usually present with a massive hemothorax, as in
our case.
1,9,10 CT-scan findings include hemothorax,
thickening of the pleura, or invasion of the chest
wall. Pleural angiosarcoma has been described in
the setting of chronic tuberculous pyothorax,
11 as
well as a long-term consequence of radiotherapy,
12
or even without any prior history, e.g. ‘‘de novo’’
tumors.
1 Diagnosis may be difficult when biopsy
samples are inconclusive, especially in the setting
of recurrent massive bleeding within the pleura.
In our case, the thoracoscopy was performed by
a physician, without double lumen intubation. It is
likely that such a procedure should be performed
by a thoracic surgeon to facilitate the diagnosis.
The positive staining for CD31, CD34 and vimentin,
as well as the negativity for epithelial markers in
the skin biopsy, together with morphologic criteria
led to the diagnosis of primary pleural angiosarcoma
metastatic to the skin and the oral mucosa. Given
the history of recurrent hemothorax that occurred
weeks before skin lesions appeared, it makes it
unlikely that the patient had pleural metastases
from cutaneous angiosarcoma. Post-mortem exami-
nation revealed a massive bilateral involvement
of the pleura, invading the lung. Bronchio-alveloar
hemorrhage was presumably the cause of the
patient’s death. Distant small skin and mucosal
localizations were presumed metastatic, and the
liver was free of either metastases or primary, as a
case of liver angiosarcoma invading the pleura was
reported to have induced a massive hemothorax.
13
The outcome of pleural angiosarcoma is dismal.
4
Chemotherapy has little effect, and may relieve
symptoms but can hardly be considered in patients
with a poor performance status. Surgery is the
best treatment for those patients who experience
more circumscribed chest wall lesions, and is the
key for long-term survival. Surgical debulking,
pneumonectomy at the most, sometimes with rib
excision in the case of chest wall tumors must be
undertaken whenever possible.
1–3,9,14–16 Radiation
Fig. 1. Thoracic CT-scan showing the bilateral hemothorax.
104 Kurtz et al.therapy may have a role in the adjuvant setting
for angiosarcoma
1,2,16 but it has little interest in
patients with distant metastasis or diffuse pleural
angiosarcoma, as in our case. Combined modality
treatment has been reported in the neoadjuvant
setting in a patient who secondarily underwent
successful surgery of a left lung inferior lobe
angiosarcoma.
8 However, neoadjuvant therapy
might delay curative surgery and should not be
recommended in current practice. Vascular emboli-
zation, as in our case, may decrease tumor feeding
as well as pleural bleeding. It has also been
performed prior to surgery, in order to decrease
tumor vascularity.
3
Massive hemothorax as the first symptom of an
angiosarcoma has been reported in a few cases.
Although pleural angiosarcoma is an extremely
rare tumor, this dramatic clinical picture should
not be misdiagnosed, in order to give the patients
the best chance for surgical or medical therapy.
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